Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Chen Yu reported a 7.20% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G)
Event Oct 10, 2025 · Filed Oct 17, 2025
Chen Yu reported a 7.20% stake in Monte Rosa Therapeutics, Inc., 4,427,705 shares, as a passive investor on Oct 10, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 7.20%
- Shares
- 4,427,705
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 3.60% | 2,213,853 |
| TCG Crossover Fund II, L.P. | 3.60% | 2,213,853 |
| TCG Crossover GP III, LLC | 3.60% | 2,213,852 |
| TCG Crossover Fund III, L.P. | 3.60% | 2,213,852 |
| Chen Yu | 7.20% | 4,427,705 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026